Patents by Inventor Graham A Mock

Graham A Mock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200123595
    Abstract: The present proposals relate to methods for detection of whole-cell bacteria, for example whole-cell pathogenic bacteria, in particular drug-resistant bacteria. These proposals also include apparatus and kits for use in such methods.
    Type: Application
    Filed: September 11, 2017
    Publication date: April 23, 2020
    Inventor: Graham Mock
  • Publication number: 20030064370
    Abstract: Disclosed is a method of detecting the presence of a nucleic acid target sequence of interest, the method comprising the steps of:
    Type: Application
    Filed: August 7, 2001
    Publication date: April 3, 2003
    Applicant: Cytocell Limited
    Inventors: Anthony Weston, Rene Assenberg, Peter Marsh, Graham A. Mock, Trevor D. Ray, Susan D. Wharam, Donald L.N. Cardy
  • Patent number: 6391593
    Abstract: Disclosed is a method of detecting a nucleic acid sequence of interest in a sample, the method comprising contacting the sample with first and second probes; the first probe comprising a portion complementary to the sequence of interest and so capable of hybridising thereto, and a portion non-complementary to the sequence of interest; the second probe comprising a portion complementary to the sequence of interest and so capable of hybridising thereto, and a portion non-complementary to the sequence of interest but complementary to that portion of the first probe which is non-complementary to the sequence of interest, such that the first and second probes are capable of hybridising to the sequence of interest in an adjacent or substantially adjacent manner, so as to allow complementary portions of the first and second probes to hybridize to each other; causing extension of the first probe with a nucleic acid polymerase, using the second probe as a template; and detecting directly or indirectly the extension of
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: May 21, 2002
    Assignee: Cytocell Limited
    Inventors: Anthony Weston, Rene Assenberg, Peter Marsh, Graham A Mock, Trevor D Ray, Susan D Wharam, Donald L. N. Cardy
  • Patent number: 6287770
    Abstract: Disclosed is a method of detecting the presence of a nucleic acid target sequence of interest, the method comprising the steps of: (a) adding first and second nucleic acid probes to a sample comprising the sequence of interest, so as to form a complex comprising three strands of nucleic acid, wherein the first probe comprises the full length sequence of a first strand of a double stranded promoter, the target sequence comprises an end part of a second strand of the double stranded promoter which is complementary to a part of the first strand, and the second probe comprises the rest of the second strand of the double stranded promoter which is complementary to a part of the first strand, such that a functional promoter is formed when the first probe is hybridized to both the target sequence and to the second probe; (b) adding a polymerase which recognizes the promoter, so as to cause the de novo synthesis of nucleic acid from the promoter present in the complex; and (c) detecting directly or indirectly the
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: September 11, 2001
    Assignee: Cytocell Limited
    Inventors: Anthony Weston, Rene Assenberg, Peter Marsh, Graham A Mock, Trevor D. Ray, Susan D Wharam, Donald L. N. Cardy
  • Patent number: 5633364
    Abstract: An oligonucleotide containing at least one cytidine analog labeled at C4 with a reporter group.
    Type: Grant
    Filed: September 17, 1992
    Date of Patent: May 27, 1997
    Assignee: Amoco Corporation
    Inventors: Graham A. Mock, Douglas H. Lovern
  • Patent number: 5405950
    Abstract: An oligonucleotide containing at least one cytidine analog labeled at C4 with a reporter group.
    Type: Grant
    Filed: October 9, 1987
    Date of Patent: April 11, 1995
    Assignee: Amoco Corporation
    Inventors: Graham A. Mock, Douglas H. Lovern
  • Patent number: 5155216
    Abstract: Polynucleotides are labeled with chemiluminescent acridine esters or luminescent lanthanides. Labelling is preferably carried out by incorporating a functional group into a nucleotide or polynucleotide at the C4 position of the pyrimidine portion or the C6 position of the purine portion and bonding a chemiluminescent acridine ester or a luminescent lanthanide to the functional group. The labeled polynucleotides are useful for direct detection of homologous polynucleotide sequences.
    Type: Grant
    Filed: April 8, 1991
    Date of Patent: October 13, 1992
    Assignee: Amoco Corporation
    Inventors: Graham A. Mock, Michael Septak, Michael J. Powell